###### Strengths and limitations of this study

-   It is large prospective cohort study with a long follow-up period.

-   Blood samples were collected at baseline and measured with standardised approaches.

-   Other information, including smoking, physical activity, educational level, alcohol consumption and anthropometric variables, was collected.

-   Only one measurement of white cell count was performed.

-   Multiple comparisons were used in the analyses, which might produce smaller p values by chance and exaggerate type I error.

Introduction {#s1}
============

White cell counts (WCC) include several cell types (lymphocytes, monocytes, neutrophils, eosinophils and basophils) and are widely considered as sensitive biomarkers of systemic inflammation. Although quite a few studies have found WCC is a good predictor of survival in patients with certain clinical diagnoses, studies on the association of this inexpensive and ubiquitous test with mortality in the healthy population are insufficient and inconsistent. A number of studies have associated WCC with cancer mortality, cardiovascular diseases (CVDs) mortality and all-cause mortality especially in elderly population or female population with limited sample size,[@R1] leaving inadequate evidence from the general population.

A few studies have shown that WCC or subtype is an independent predictor of mortality after controlling for potential confounding, for example, smoking.[@R1] This conclusion, however, might conflict with the fact that the WCC is influenced by many factors, such as infection, inflammation, smoking and obesity. Cigarette smoking is a well-recognised cause of elevated WCC.[@R13] Smokers have higher WCC than non-smokers, and the extent of the increase rises with the number of cigarettes smoked.[@R15] Obesity, an important risk factor for the development of CVD such as hypertension, diabetes and dyslipidaemia, is also associated with substantial increases in WCC.[@R16] Therefore, the association of WCC or subtype on mortality might be mediated by smoking or obesity, however, a few studies have investigated whether WCC or subtype played a mediate role on the pathway from smoking to mortality, or from obesity to mortality, or whether the three factors play a joint role on mortality.

Evidence of WCC subtype as a predictor of mortality in healthy populations is limited and largely inconsistent. Higher neutrophils[@R2] or lower lymphocytes[@R3] were associated with increased mortality, but no associations were found in other subtype in the same study.[@R3] Several studies have shown that monocyte counts have been independently associated with all-cause,[@R2] CVD[@R2] or cancer-related mortality,[@R2] while other studies have reported no association.[@R3] A U-shaped association of eosinophil count with all-cause mortality was reported in a Danish study.[@R23] Smoking or obesity has been associated with differential WCC subtype,[@R24] while whether this impacts mortality differently is unknown. Due to the differential function of WCC subtype in the immune system, more studies on mortality of general populations are warranted.

In order to further clarify the role of WCC and its subtype on the risk of all-cause, CVD and cancer mortality, we initiated an analysis using data from the European Prospective Investigation into Cancer and Nutrition-Netherlands (EPIC-NL), a prospective cohort recruited from the generally healthy population in the Netherlands.[@R26] Specifically, we gauged the relation of WCC and its subtype with smoking and obesity, and further examined the joint effect of those factors on mortality.

Materials and methods {#s2}
=====================

Study population {#s2-1}
----------------

This prospective cohort study combines the two Dutch cohorts of the EPIC, the EPIC-Medical Ethical Committee of TNO Nutrition and Food Research (MORGEN) and EPIC-Prospect,[@R27] which were set up simultaneously between 1993 and 1997. The EPIC-Prospect study includes 17 357 women aged 49--70 years living in Utrecht and its vicinity who participated in the nationwide Dutch breast cancer screening programme. The EPIC-MORGEN cohort consists of 22 654 men and women aged 21--64 years selected from random samples of the Dutch population in three different towns (Doetinchem, Amsterdam, Maastricht). At baseline, all participants filled out a general questionnaire and a validated food frequency questionnaire and underwent a physical examination. All participants provided written informed consent before study inclusion.

Beginning June 1995, after 19 214 subjects had been enrolled, a blood sample was drawn of all subsequent subjects for measurement of blood cell count at entry into the cohort. For the remaining inclusion period, blood cell counts were not available in some cohort participants. Moreover, valid smoking data were missing for 156 subjects. With further removal of 253 participants who never had followed up, we initially had 15 973 participants included in this study. Participants with a baseline history of cancer (n=555), stroke and heart diseases (n=397), diabetes (n=259) and comorbidity of above two or three diseases (n=86) were excluded. Moreover, participants with missing values (n=243) were further excluded. A total of 14 433 (4150 men and 10 283 women) participants were included in the present study.

Patient and public involvement {#s2-2}
------------------------------

We appreciated all patients who participated in the study and contributed their personal information to the research. All patients and the public, however, were not involved in the design or planning of the study.

### Blood collection {#s2-2-1}

The blood sample for measurement of the complete blood cell count was drawn in an ethylenediaminetetraacetic acid (EDTA) Monovette at entry into the cohort. The storage process as well as the analysis of blood samples was described previously.[@R13] Total WCC and subtypes, including absolute counts of lymphocytes, monocytes, neutrophils and eosinophils, were measured using standard automated clinical methodologies.

### Covariates {#s2-2-2}

Information on sex (male, female), age (years) at study entry, educational level, smoking habit, alcohol consumption and physical activity was obtained by questionnaire. Educational level was grouped into four categories: primary school, technical/professional education, secondary school and longer education (including university). Smoking was defined as never, former (quit smoking \>20 years ago, quit 10--20 years ago, quit ≤10 years ago) and current smoker (1--15, 16--25, \>16 cigarettes/day), therefore coding included seven categories. Smokers were also asked if they were pipe or cigar smoker. Alcohol consumption was considered as a continuous variable (gram of ethanol/day). Physical activity was categorised into four levels: inactive, moderately inactive, moderately active or active according to the validated Cambridge Physical Activity Index.[@R28] Body mass index (BMI, kg/m^2^) was calculated dividing body weight (kg) by the square of the body height (m^2^), and waist circumferences were measured by centimetres.

### Outcome assessment {#s2-2-3}

The outcomes of interest were all-cause, cancer and CVD mortality. EPIC-NL participants were followed for vital status and date of death by regular linkage with the municipal registries. Subsequently, causes of death for deceased persons were obtained through linkage with Statistics Netherlands. Follow-up was complete through 31 December 2012.

### Statistical analyses {#s2-2-4}

Descriptive statistics of baseline characteristics are presented for all participants by categories of WCC. Cox proportional hazards regression models were used to estimate the HR and 95% CI of the associations between WCC, its subtypes (lymphocytes, monocytes, neutrophils and eosinophils) and all-cause, cancer and CVD mortality. Distributions of WCC are shown by tertiles (T~1~=WCC ≤5.7×10^9^/L; T~2~=WCC \>5.7×10^9^/L -\<7.2×10^9^/L; T~3~=WCC ≥7.2×10^9^/L). Categories based on clinical standard ranges were also considered and analysed. Due to limited number in certain categories using clinical standard range, we only reported results based on tertiles. The follow-up of all participants in the cohort started since the date of study entry, and censored at the date of death, lost to follow-up or 31 December 2012, whichever came first. We used attained age as the time scale in the Cox regression model. Proportional hazard assumption was tested based on Schoenfeld residuals. In some models, sex did not meet the assumption. We then set it as a strata variable. Cox regression models were stratified by age (set as an integer) and sex and were adjusted for potential confounders: educational level, smoking habit, alcohol consumption, physical activity, BMI and waist circumference. Linear trend across tertiles was assessed by modelling the median of each tertile as a continuous variable. To test for effect modification of WCC and subtypes on mortality risk by BMI, waist circumference or smoking, we used a likelihood ratio test to compare the model with and without interaction terms.

In order to measure the joint effect of BMI, smoking and WCC, a new variable was created by combining BMI (\<25 and ≥25 kg/m^2^), WCCcategories (≤10, \>10×10^9^ cells/L, based on clinical standard range) and smoking status (no smoking or ever smoking). The combined category of normal WCC range (≥4 to ≤10×10^9^ cells/L) with BMI \<25 kg/m^2^ and never smoking was chosen as reference. Analyses of joint effects were controlled for age and sex in the basic model (model 1), or age, sex, alcohol consumption, physical activity and educational level in the second model.

In order to assess if counts of WCC are a mediating factor between smoking, or obesity and risk of mortality, we performed a mediation analysis based on counterfactual mediation modelling.[@R29] Proportion mediated was calculated based on indirect effects divided by total effects. This method, unfortunately, has not been well developed in application to time-to-event data. Therefore, we also calculated mediation using the traditional 'change-in-estimate' method.[@R32] We calculated the quantification of the percentage reduction in estimate (smoking) after controlling for the potential mediating factor (WCC).

Two-sided p\<0.05 were considered to be statistically significant. All statistical analyses were conducted using the statistical software package STATA V.12.0 (StataCorp).

Results {#s3}
=======

Baseline characteristics {#s3-1}
------------------------

A total of 14 433 participants were included in the analysis with a mean follow-up of 15.8±2.4 years. There were 936 total deaths over 228 304 person-years of follow-up. The crude cumulative mortality rate was 4.1 per 1000 person-years. Among total deaths, 466 were due to cancer, 179 due to CVDs and 291 due to other causes.

Baseline characteristics of the participants by tertile of WCC are reported in [table 1](#T1){ref-type="table"}. Proportions of men and women were similar across tertiles of WCC. Participants were younger, more obese, less educated, less active physical activity and more current smokers in the higher tertiles of WCC, while alcohol consumption was similar across the tertiles of WCC. Analysis of WCC subtypes revealed significantly higher lymphocyte, monocyte, neutrophil and eosinophils levels among all-cause and disease-specific mortality cases compared with all participants.

###### 

Basic characteristics of cohort participants by tertiles of white cell count (WCC)

                                           WCC                                                                   
  ---------------------------------------- ----------- ----------- ----------- ----------- ------ ------- ------ -------
  N                                        14 433                  5146                    4514           4773   
   Men (%)                                 4150        28.75       1502        29.19       1316   29.15   1332   27.91
   Women (%)                               10 283      71.25       3644        70.81       3198   70.85   3441   72.09
  Age at recruitment (mean±SD)             47.3±11.8   48.1±12.0   47.1±12.0   46.7±11.3                         
  BMI, n (%)                                                                                                     
   \<25 kg/m^2^                            7022        48.65       2702        52.51       2113   46.81   2207   46.24
   ≥25 to \<30 kg/m^2^                     5539        38.38       1925        37.41       1784   39.52   1830   38.34
   ≥30 kg/m^2^                             1872        12.97       519         10.09       617    13.67   736    15.42
  Waist size (cm)                          85.1        ±11.5       83.6        ±10.7       85.3   ±11.5   86.3   ±12.1
  Educational level, n (%)                                                                                       
   Primary school                          1794        12.43       546         10.61       571    12.65   677    14.18
   Technical/professional                  5082        35.21       1760        34.20       1540   34.12   1782   37.34
   Secondary school                        4078        28.25       1439        27.96       1279   28.33   1360   28.49
   Longer education (inclu. university)    3479        24.10       1401        27.23       1124   24.90   954    19.99
  Physical activity, n (%)                                                                                       
  Inactive                                 1015        7.03        249         4.84        306    6.78    460    9.64
   Moderately inactive                     3510        24.32       1206        23.44       1065   23.59   1239   25.96
   Moderately active                       3850        26.67       1420        27.59       1209   26.78   1221   25.58
   Active                                  6058        41.97       2271        44.13       1934   42.84   1853   38.82
  Smoking habits, n (%)                                                                                          
   Never                                   5479        37.96       2462        47.84       1774   39.30   1243   26.04
   Former                                  4455        30.87       1889        36.71       1499   33.21   1067   22.35
   Current                                 4499        31.17       795         15.45       1241   27.49   2463   51.60
  Alcohol intake, gram/day (median, IQR)   5.9         ±16.2       6.1         ±15.1       5.9    ±16.2   5.8    ±18.1

BMI, body mass index.

Association between total WCC, its subtypes and mortality {#s3-2}
---------------------------------------------------------

The association between WCC, its subtypes and all-cause, cancer and CVD mortality is shown in [table 2](#T2){ref-type="table"}. After multivariate adjustment, a statistically significant association between total WCC (HR~T3vsT1~: 1.38, 95% CI 1.17 to 1.64, p\<0.0001), lymphocytes (HR~T3vs\ T1~: 1.21, 95% CI 1.02 to 1.43, p=0.025), monocytes (HR~T3vs\ T1~: 1.22, 95% CI 1.04 to 1.43, p=0.016), neutrophils (HR~T3vs\ T1~: 1.29, 95% CI 1.09 to 1.52, p=0.002) and eosinophils (HR~T3vs\ T1~: 1.25, 95% CI 1.05 to 1.49, p=0.017) and all-cause mortality risk was observed. A significant association was observed between total WCC and CVD mortality (HR~T3vs\ T1~: 1.53, 95% CI 1.03 to 2.26, p=0.031), but not cancer mortality (HR~T3vs\ T1~: 1.13, 95% CI 0.89 to 1.44, p=0.282). The associations for subtypes of WCC were not statistically significant for cancer and CVD mortality. No significant association was found for neutrophil-to-Lymphocyte ratio (NLR) and mortality ([table 2](#T2){ref-type="table"}).

###### 

HRs and 95% CIs of WCC and its subtype relative to mortality

                          N        All cause of death   Cancer death   CVD death                                                           
  ---------------- ------ -------- -------------------- -------------- ----------- ----- ------- ------ ------- ---- ------- ------ ------ --
  Total (N)               14 433   936                                                   466                         179                   
  WCC              T~1~   5146     274                  1                                144     1                   47      1             
  T~2~             4514   252      1.01                 0.85           1.21        122   0.90    0.70   1.15    53   1.20    0.81   1.79   
  T~3~             4773   410      1.38                 1.17           1.64        200   1.13    0.89   1.44    79   1.53    1.03   2.26   
  P trend                          \<0.0001                            0.282                            0.031                              
  Subtype of WCC                                                                                                                           
  Lymphocytes      T~1~   4904     282                  1                                131     1                   50      1             
  T~2~             4985   306      1.08                 0.92           1.28        160   1.18    0.93   1.49    61   1.19    0.81   1.74   
  T~3~             4544   348      1.21                 1.02           1.43        175   1.22    0.95   1.55    68   1.33    0.90   1.96   
  P trend                          0.025                                                 0.119                       0.154                 
  Monocytes        T~1~   7387     455                  1                                225     1                   76      1             
  T~2~             2990   170      1.02                 0.85           1.22        90    1.07    0.84   1.38    41   1.40    0.95   2.06   
  T~3~             4056   311      1.22                 1.04           1.43        151   1.15    0.92   1.44    62   1.33    0.92   1.92   
  P trend                          0.016                                                 0.23                        0.105                 
  Neutrophils      T~1~   5008     269                  1                                138     1                   48      1             
  T~2~             4927   285      0.94                 0.80           1.11        149   0.95    0.75   1.21    58   1.01    0.69   1.49   
  T~3~             4498   382      1.29                 1.09           1.52        179   1.07    0.84   1.36    73   1.35    0.92   1.99   
  P trend                          0.002                                                 0.572                       0.11                  
  Eosinophils      T~1~   7911     484                  1                                245     1                   83      1             
  T~2~             3881   262      1.06                 0.91           1.23        120   0.93    0.75   1.17    59   1.28    0.91   1.80   
  T~3~             2641   190      1.25                 1.05           1.49        101   1.25    0.98   1.59    37   1.30    0.87   1.95   
  P trend                          0.017                                                 0.159                       0.135                 
  NLR\*            T~1~   4831     275                  1                                146     1                   48      1             
  T~2~             4796   327      1.13                 0.96           1.32        172   1.14    0.91   1.43    59   1.15    0.78   1.68   
  T~3~             4805   334      1.09                 0.93           1.29        148   0.91    0.72   1.15    72   1.34    0.92   1.94   
  P trend                          0.303                                                 0.431                       0.303                 

\*Model adjusted by age and sex, alcohol consumption, physical activity, educational level, BMI, waist circumference and smoking intensity.

BMI, body mass index; CVD, cardiovascular disease; NLR, neutrophil-to-lymphocyte ratio; WCC, white cell count.

Total WCC, its subtype and mortality by smoking status {#s3-3}
------------------------------------------------------

Interactions between WCC (or its subtype) and smoking status were consistently significant, while no interaction was found for WCC and BMI, or waist circumference except eosinophils and waist circumference. We further stratified the analyses by smoking status ([table 3](#T3){ref-type="table"}). The results showed that total WCC and all WCC subtypes were statistically significantly associated with total mortality in current smokers, while the associations were attenuated or disappeared in never and former smokers. Total WCC and lymphocytes were significantly associated with cancer mortality risk in current smokers, whereas only total WCC was significantly associated with CVD mortality in current smokers (data not shown). In former smokers, the NLR was positively associated with CVD mortality, but monocytes count was negatively associated with CVD mortality.

###### 

HRs and 95% CIs of white cell count (WCC) and its subtype relative to mortality stratified by smoking status

                          N      Never smoking   N      Former smoking   N      Current smoking                                                               
  ---------------- ------ ------ --------------- ------ ---------------- ------ ----------------- ------ ------ ------ ------ ------ ---------- ------ ------ --
  WCC              T~1~   2462   135             1.00                           1889              104    1                    795    35         1.00          
  T~2~             1774   75     0.77            0.58   1.03             1499   82                0.96   0.71   1.3    1241   95     1.69       1.14   2.50   
  T~3~             1243   87     1.24            0.94   1.63             1067   67                1.15   0.83   1.58   2463   256    2.03       1.41   2.92   
  P trend                        0.27                                                             0.45                               \<0.0001                 
  Subtype of WCC                                                                                                                                              
  Lymphocytes      T~1~   2261   138             1.00                           1762              95     1                    881    49         1.00          
  T~2~             1959   89     0.76            0.58   1.00             1599   90                1.05   0.77   1.42   1427   127    1.70       1.22   2.37   
  T~3~             1259   70     1.01            0.75   1.36             1094   68                1.09   0.78   1.51   2191   210    1.65       1.20   2.27   
  P trend                        0.75                                                             0.62                               0.01                     
  Monocytes        T~1~   3240   177             1.00                           2384              142    1                    1763   136        1.00          
  T~2~             1079   62     1.29            0.96   1.72             1004   50                0.83   0.59   1.17   907    58     0.91       0.67   1.24   
  T~3~             1160   58     1.18            0.87   1.60             1067   61                0.87   0.63   1.21   1829   192    1.39       1.10   1.77   
  P trend                        0.17                                                             0.35                               0.01                     
  Neutrophils      T~1~   2268   127             1.00                           1794              92     1                    946    50         1.00          
  T~2~             1942   87     0.70            0.53   0.93             1630   99                1.13   0.84   1.52   1355   99     1.09       0.77   1.54   
  T~3~             1269   83     1.01            0.76   1.33             1031   62                1.21   0.87   1.69   2198   237    1.62       1.18   2.21   
  P trend                        0.75                                                             0.25                               \<0.0001                 
  Eosinophils      T~1~   3266   180             1.00                           2588              135    1                    2057   169        1.00          
  T~2~             1377   79     1.06            0.81   1.39             1129   70                1.07   0.79   1.45   1375   113    1.02       0.80   1.31   
  T~3~             836    38     0.94            0.66   1.35             738    48                1.27   0.89   1.81   1067   104    1.43       1.10   1.86   
  P-trend                        0.92                                                             0.21                               0.01                     
  NLR\*            T~1~   1877   83              1.00                           1535              78     1                    1419   114        1.00          
  T~2~             1827   103    1.15            0.86   1.54             1484   103               1.30   0.96   1.76   1485   121    1.00       0.77   1.30   
  T~3~             1775   111    1.13            0.84   1.51             1435   72                0.99   0.71   1.38   1595   151    1.08       0.85   1.39   
  P trend                        0.43                                                             0.99                               0.51                     

\*Model adjusted by age and sex, alcohol consumption, physical activity, educational level, BMI, waist circumference.

BMI, body mass index; NLR, neutrophil-to-lymphocyte ratio.

Joint effects of BMI, smoking, WCC and mortality {#s3-4}
------------------------------------------------

A high WCC BMI in addition to being a current or former smoker was strongly and significantly associated with all-cause and cancer mortality risk, regardless of BMI status ([table 4](#T4){ref-type="table"}). Subjects with BMI \<25 kg/m^2^ who were also current or former smokers with normal WCC showed an increased risk for all-cause and cancer mortality (HR 1.55, 95% CI 1.21 to 1.99; HR 2.00, 95% CI 1.37 to 2.92, respectively). This association was not strengthened when BMI was elevated (HR 1.42, 95% CI 1.11 to 1.80; HR 1.80, 95% CI 1.25 to 2.60, respectively), but apparently enhanced when WCC increases irrespective of level of BMI (in those with BMI \<25 hours 3.15, 95% CI 2.07 to 4.81; HR 2.71, 95% CI 1.37 to 5.38 and in those with BMI ≥25 HR 3.92, 95% CI 2.76 to 5.57; HR 3.93, 95% CI 2.30 to 6.72, respectively).

###### 

Joint effect of BMI, smoking status and white cell count (WCC) on mortality

  BMI     Smoking         WCC (clinical ranges)   N     All-cause mortality   N          Cancer mortality                                                                                         
  ------- --------------- ----------------------- ----- --------------------- ---------- ------------------ ------ ---------- ---------- ------ ----- ------ ------ ------- ------ ------ ------- ------
  \<25    Never           \<4.0                   132   6                     0.89       0.36               2.20   0.83       0.34       2.05   132   1      0.47   0.06    3.42   0.45   0.06    3.26
  Never   ≥4.0 to ≤10.0   2433                    89    Referent              Referent   2433               36     Referent   Referent                                                            
  Never   \>10.0          50                      4     2.13                  0.78       5.85               1.99   0.73       5.45       50     2     2.87   0.68   12.05   2.75   0.66   11.55   
  Ever    \<4.0           125                     9     1.45                  0.73       2.88               1.45   0.73       2.89       125    7     2.66   1.18   5.99    2.61   1.15   5.89    
  Ever    ≥4.0 to ≤10.0   3971                    228   1.66                  1.30       2.13               1.55   1.21       1.99       3971   126   2.15   1.48   3.12    2.00   1.37   2.92    
  Ever    \>10.0          311                     30    3.63                  2.39       5.52               3.15   2.07       4.81       311    11    3.03   1.54   6.00    2.71   1.37   5.38    
  ≥25     Never           \<4.0                   90    6                     1.24       0.54               2.85   1.16       0.51       2.65   90    4      1.96   0.69    5.52   1.81   0.64    5.12
  Never   ≥4.0 to ≤10.0   2711                    187   1.23                  0.96       1.59               1.14   0.88       1.47       2711   84    1.43   0.96   2.11    1.35   0.91   2.00    
  Never   \>10.0          63                      5     1.54                  0.63       3.81               1.41   0.57       3.49       63     1     0.82   0.11   5.99    0.78   0.11   5.69    
  Ever    \<4.0           84                      2     0.45                  0.11       1.84               0.42   0.10       1.71       84     1     0.55   0.08   4.04    0.52   0.07   3.83    
  Ever    ≥4.0 to ≤10.0   4111                    317   1.57                  1.23       1.99               1.42   1.11       1.80       4111   170   1.97   1.37   2.84    1.80   1.25   2.60    
  Ever    \>10.0          352                     53    4.71                  3.33       6.65               3.92   2.76       5.57       352    23    4.53   2.66   7.71    3.93   2.30   6.72    

Model 1: adjusted by sex and age. Model 2: model 1+alcohol consumption, physical activity and education.

BMI, body mass index.

Mediation analysis {#s3-5}
------------------

Based on the potential causality pathway and previous evidence between smoking and WCC or obesity and WCC, we tested mediation of WCC between smoking (ever smoker vs never smoker) and total mortality, and between overweight (BMI \>25 vs BMI ≤25 kg/m^2^) and total mortality, when smoking was treated as a primary exposure in the model. Using the counterfactual mediation modelling, we calculated the total effect, direct effect and indirect effect based on Cox regression model and linear regression model. The proportion mediated was 32.7% (95% CI 30.1% to 41.1%) for smoking, and 6.4% (95% CI 5.3% to 5.9%) for BMI. Using the 'change-in-estimate' method, the proportion mediated was 27.9% (95% CI 19.1% to 49.4%) for smoking and 9.6% (95% CI 5.5% to 38.3%) for BMI.

Discussion {#s4}
==========

In this longitudinal study, we found that higher counts of total WCC and its subtypes are positively associated with a significantly higher risk of all-cause mortality. Highest risk of all-cause mortality was observed in ever smokers with elevated total WCC and higher BMI. WCC may be one of the mediating factors in the association between smoking or BMI and all-cause mortality.

Several previous studies have reported that WCC was associated with mortality even after adjusting for smoking.[@R1] This is not fully consistent with our analysis in healthy population. In our study, the associations between total WCC and mortality were attenuated when smoking was incorporated into the model. In the analysis stratified by smoking status, all cause, CVD and cancer mortality were especially stronger in current smokers. Current cigarette smoking has been associated with increased WCC in many studies.[@R15] Our data show that current smoking is also strongly related to WCC. The existence of low-grade inflammation in smokers may trigger the increase of WCC that fights against the inflammation and damage caused by smoking.[@R13] Interestingly, several studies have demonstrated that current cigarette smoking is a reversible cause of elevated WCC and quitting of smoking may lead to recovery of WCC.[@R34] The non-significant results in former smokers in our study may further verify this point. Moreover, obesity has been defined as a state of chronic low-grade inflammation in which leucocytes might be involved.[@R36] Quite a few studies have observed increased WCC among subjects with overweight or obesity[@R7] suggesting that leucocytes are involved in the development of obesity-related comorbidities. Stratified analysis by smoking status and joint effect analysis by smoking and BMI status showed apparent evidence for effect modification by smoking and BMI. The further mediation analyses indicated that WCC or its subtype may play in part a mediating role from smoking to mortality, or from obesity to mortality. In fact, the strongest associations between an increased total WCC and all-cause and cancer mortality were observed in ever smoking participants with BMI ≥25 kg/m^2^.

Few studies have investigated the risk associated with different WCC subtypes in healthy subjects. Our study showed that subtype of WCC was significantly associated with all-cause mortality after adjustment for smoking (status, intensity and duration), while the associations with cancer and CVD mortality were attenuated and became non-significant. Most previous studies that have evaluated WCC subtype with risk of mortality have been conducted in CVD subjects or patients with cancer, and few in general populations. Among healthy participants at baseline, an Asian cohort study (245 died in 8447 study subjects) showed an inverse association between lymphocyte count and all-cause and cancer mortality, while neutrophil and monocyte counts were positively associated with CVD mortality.[@R39] The Women's Health and Aging Study (175 died in 624 community-dwelling women age 65--101) demonstrated that high total WCC, high neutrophil counts and low lymphocyte counts were associated with all-cause mortality[@R3] while among elderly subjects, monocyte counts were associated with an increased risk of cardiovascular and cancer-related mortality.[@R2] In a recent study from the UK (10 364 died in 478 259 study participants), neutrophil counts were associated with total mortality and CVD mortality, especially consistently associated with fatal and non-fatal CVD in men.

It is important to evaluate WCC subtypes for several reasons. First, they differ in their inflammation and immune functions. In addition, the different associations observed between the WCC subtypes and the outcomes considered (all-cause, cancer and CVD mortality) confirm their differential roles in the organism. Inflammation plays an essential part in initiating tumourigenesis by damaging specific tissues, and neutrophils, monocytes and eosinophils are crucial components of this process.[@R40] However, in the present study, a stronger association was shown between total WCC and all-cause, cancer and CVD mortality compared with the subtypes. In contrast to our findings, several studies have shown high neutrophil and low lymphocyte counts (the increased NLR) associated with mortality in general population. However, the NLR displayed no association with mortality in our study, while a significantly increased association was observed in persons who died of CVD before 70 years (data not showed). More interestingly, when we analysed the association of the NLR with total mortality by 1, 5, 6 and 10 years follow-up, respectively (data not shown), we found the NLR is significantly associated with total mortality in short period of follow-up until 5 years but not in 6 years or 10 years. It has been reported that the NLR is sensitive to the suppressive action of particularly activated myeloid cells. It may reflect the phenotypic action of a disease process and thus be less evident in a long prospective setting. Some studies have shown that the NLR was a good predictor of mortality[@R41] in patients with CVDs or cerebrovascular disease, while our study participants were from the general population in which the role of NLR might be different. The NLR can reflect the balance between the activation of the inflammation pathway and the anti-inflammation immune function, and is a good biomarker for acute inflammation. Therefore, the NLR can be a good predictor for patients with acutely clinical symptoms but not for mortality in general population.

A number of limitations of these analyses must be considered. Only one measurement of WCC was performed. Multiple comparisons were used in the analyses, which might produce smaller p values by chance and exaggerate type I error. Some death cases (n=62) could not be classified because (1) the participant did not consent for linkage with causes of death database (n=18); (2) an error occurred in the linkage procedure (n=42) and (3) for unknown reasons (n=2). Even after adjustment for the known risk factors, residual confounding may occur because of measurement error or unmeasured or unknown risk factors.

The present study has several strengths that should be emphasised as well. EPIC-NL is a large prospective cohort study that included both men and women from the general population, with a broad age range and a long follow-up period. Blood samples were collected at baseline and measured with standardised approaches. Information, including smoking, physical activity, educational level, and alcohol consumption, was collected using a structured questionnaire. Anthropometric variables were measured using standardised procedures. The cause of death of deceased participants was obtained through linkage with the municipal registry and Statistics Netherlands.

In summary, WCC and its subtypes are associated with an increased risk of all-cause mortality, and total WCC is associated with cancer and CVD mortality. WCC may play a partially mediate role on the pathway between smoking and mortality risk, and between obesity and mortality, when smoking was treated as a primary exposure.
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